Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ACUTAccustem Sciences Inc.

OTC · CIK 0001850767
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts127

Identity from submissions API

NameAccustem Sciences Inc.
CIK0001850767
TickersACUT
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone442070661000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • AccuStem Sciences Ltd (2021-03-12T00:00:00.000Z → 2021-07-01T00:00:00.000Z)
Business address
5 PENN PLAZA, 19TH FLOOR
#1954
NEW YORK
NY
10001
NY
Mailing address
5 PENN PLAZA, 19TH FLOOR
#1954
NEW YORK
NY
10001
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

78 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 10-Q 10-Q 0001493152-26-053362 000-56257 261576683 34 4773149 1 1
2026-11-16 NT 10-Q NT 10-Q 0001493152-26-052432 000-56257 261561744 34 30144
2026-08-14 10-Q 10-Q 0001493152-26-038323 000-56257 261281334 34 3862212 1 1
2026-05-15 10-Q 10-Q 0001493152-26-023742 000-56257 26987041 34 3631140 1 1
2026-04-14 10-K 10-K 0001493152-26-016559 000-56257 26861158 34 5413892 1 1
2026-03-31 NT 10-K NT 10-K 0001493152-26-013809 000-56257 26817080 34 29889
2025-11-26 8-K 8-K 8.01 0001493152-25-025156 000-56257 251530447 34 199988 1 1
2025-11-12 10-Q 10-Q 0001493152-25-021919 000-56257 251472806 34 3815939 1 1
2025-08-14 10-Q 10-Q 0001641172-25-023786 000-56257 251215651 34 3787790 1 1
2025-06-16 4 xslF345X05/ownership.xml 0001641172-25-015197 6463
2025-06-13 4 xslF345X05/ownership.xml 0001641172-25-015003 6465
2025-05-20 10-Q 10-Q 0001641172-25-011721 000-56257 25968986 34 3602616 1 1
2025-05-15 NT 10-Q NT 10-Q 0001641172-25-011029 000-56257 25954600 34 29729
2025-04-10 4 xslF345X05/ownership.xml 0001641172-25-003618 6465
2025-04-08 4 xslF345X05/ownership.xml 0001641172-25-003222 8086
2025-04-03 10-K form10-k.htm 0001641172-25-002594 000-56257 25810524 34 5465926 1 1
2025-03-31 NT 10-K formnt10-k.htm 0001641172-25-001735 000-56257 25793439 34 29781
2025-02-21 SEC STAFF ACTION filename1.pdf 9999999997-25-000523 4035
2025-01-03 4 xslF345X05/ownership.xml 0001493152-25-000211 4856
2025-01-02 8-K/A form8-ka.htm 4.01 0001493152-25-000089 000-56257 25502861 34 216676 1 1
2024-12-30 8-K form8-k.htm 4.01 0001493152-24-052550 000-56257 241590558 34 210143 1 1
2024-11-18 10-Q form10-q.htm 0001493152-24-046438 000-56257 241469862 34 4234621 1 1
2024-11-14 NT 10-Q formnt10-q.htm 0001493152-24-046018 000-56257 241463967 34 32103
2024-09-16 10-Q form10-q.htm 0001493152-24-036330 000-56257 241300499 34 4183565 1 1
2024-08-14 NT 10-Q formnt10-q.htm 0001493152-24-032408 000-56257 241209527 34 30310
2024-05-20 10-Q form10-q.htm 0001493152-24-020584 000-56257 24962800 34 3373757 1 1
2024-05-15 NT 10-Q formnt10-q.htm 0001493152-24-019695 000-56257 24949169 34 29650
2024-04-10 8-K form8-k.htm 4.01,9.01 0001493152-24-014171 000-56257 24835151 34 216479 1 1
2024-03-22 10-K form10-k.htm 0001493152-24-010938 000-56257 24774441 34 5054636 1 1
2023-11-13 10-Q form10-q.htm 0001493152-23-040286 000-56257 231394903 34 4483550 1 1
2023-08-14 10-Q form10-q.htm 0001493152-23-028164 000-56257 231167560 34 3865973 1 1
2023-06-09 8-K form8-k.htm 5.02 0001493152-23-020727 000-56257 231005458 34 201557 1 1
2023-06-07 8-K form8-k.htm 7.01,9.01 0001493152-23-020328 000-56257 23997441 34 7538766 1 1
2023-05-05 10-Q form10-q.htm 0001493152-23-015555 000-56257 23892769 34 3600509 1 1
2023-04-28 10-K/A form10-ka.htm 0001493152-23-014112 000-56257 23862278 34 505666 1 1
2023-02-15 10-K form10-k.htm 0001493152-23-005208 000-56257 23635614 34 4654355 1 1
2023-01-19 S-1/A forms-1a.htm 0001493152-23-001932 333-268438 23537926 33 7406387 1 1
2023-01-03 4 xslF345X03/ownership.xml 0001493152-23-000064 4766
2022-12-05 4 xslF345X03/ownership.xml 0001493152-22-034396 4767
2022-11-22 4 xslF345X03/ownership.xml 0001493152-22-033239 4768
2022-11-17 S-1 forms-1.htm 0001493152-22-032755 333-268438 221398232 33 34453416 1 1
2022-11-16 8-K form8-k.htm 5.02,9.01 0001493152-22-032628 000-56257 221395334 34 219498 1 1
2022-11-08 10-Q form10-q.htm 0001493152-22-030905 000-56257 221367794 34 3419490 1 1
2022-10-14 8-K form8-k.htm 5.07 0001493152-22-028454 000-56257 221311392 34 217466 1 1
2022-10-11 DEFA14A formdefa14a.htm 0001493152-22-028031 000-56257 221302282 34 30316
2022-09-14 DEF 14A formdef14a.htm 0001493152-22-025862 000-56257 221243062 34 364972
2022-09-02 PRE 14A formpre14a.htm 0001493152-22-024958 000-56257 221224971 34 364680
2022-08-12 10-Q form10-q.htm 0001493152-22-022218 000-56257 221158427 34 3903414 1 1
2022-08-02 4 xslF345X03/ownership.xml 0001493152-22-020942 4768
2022-07-29 DRS filename1.htm 0001493152-22-020707 377-06299 221120779 33 3016658
2022-06-21 8-K form8-k.htm 5.02 0001493152-22-017353 000-56257 221027636 34 202012 1 1
2022-06-09 4 xslF345X03/ownership.xml 0001493152-22-016256 4768
2022-05-27 3 xslF345X02/ownership.xml 0001493152-22-015265 5625
2022-05-27 3 xslF345X02/ownership.xml 0001493152-22-015263 5017
2022-05-27 3 xslF345X02/ownership.xml 0001493152-22-015261 4649
2022-05-20 10-Q form10-q.htm 0001493152-22-014587 000-56257 22947373 34 3274431 1 1
2022-05-17 NT 10-Q formnt10-q.htm 0001493152-22-014008 000-56257 22931490 34 29712
2022-04-27 4 xslF345X03/ownership.xml 0001493152-22-011318 6410
2022-04-18 10-K form10-k.htm 0001493152-22-010172 000-56257 22830956 34 820128
2022-04-05 8-K form8-k.htm 1.01,3.02,5.02,9.01 0001493152-22-009142 000-56257 22806101 34 85390
2022-03-31 NT 10-K formnt10-k.htm 0001493152-22-008298 000-56257 22790072 34 29415
2022-03-10 8-K form8-k.htm 5.02,9.01 0001493152-22-006524 000-56257 22729638 34 68117
2022-01-14 3 xslF345X02/ownership.xml 0001493152-22-001231 4967
2021-12-09 3 xslF345X02/ownership.xml 0001493152-21-030964 2931
2021-12-03 3 xslF345X02/ownership.xml 0001493152-21-030433 5230
2021-12-03 8-K form8-k.htm 1.01,2.01,3.02,5.02,5.03,5.05,8.01,9.01 0001493152-21-030432 000-56257 211470179 34 842198
2021-07-01 EFFECT xslEFFECTX01/primary_doc.xml F-6,,2021-07-01 09:00:00 9999999995-21-002629 333-257315 211067897 33 1698
2021-07-01 SEC STAFF ACTION filename1.pdf 9999999997-21-003863 14838
2021-06-23 F-6 REGISTRATION STATEMENT 0001387131-21-006805 333-257315 211038590 33 506338
2021-06-07 UPLOAD filename1.pdf 0000000000-21-007046 39633
2021-06-01 20FR12G/A 20FR12G/A 0001193125-21-177289 000-56257 21982160 34 907540
2021-05-28 CORRESP filename1.htm 0001193125-21-177291 31345
2021-05-14 UPLOAD filename1.pdf 0000000000-21-006154 46176
2021-05-07 20FR12G/A 20FR12G/A 0001193125-21-153538 000-56257 21899433 34 897980
2021-05-06 CORRESP filename1.htm 0001193125-21-153542 81028
2021-05-03 UPLOAD filename1.pdf 0000000000-21-005620 40860
2021-04-08 UPLOAD filename1.pdf 0000000000-21-004275 61866
2021-03-12 20FR12G 20FR12G 0001193125-21-078642 000-56257 21735417 34 2265672

Latest XBRL company facts

One latest value per concept from companyfacts (127 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 16.07M 2026-11-20 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
dei EntityPublicFloat Entity Public Float USD 9.68M 2025-06-30 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 640,022 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 369,528 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 17,527 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 11,100 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 10,999 2025-12-31 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 66,981 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 6.40M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 29,847 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021919
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap Assets Assets USD 83,201 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap AssetsCurrent Assets, Current USD 83,201 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap Cash Cash USD 15,303 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 15,303 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 1,374 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 0 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 16.07M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 16.07M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap CommonStockValue Common Stock, Value, Issued USD 16,072 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -833,341 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-05 0001493152-23-015555
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 1.34M 2022-03-01 2022-03-31 2022 Q3 10-Q 2022-11-08 0001493152-22-030905
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 7,606 2025-06-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-023786
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 137,753 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.09M 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 1.84M 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 91,161 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 426 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 88,423 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.09M 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap Depreciation Depreciation USD 418 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap DueFromRelatedParties Due from Related Parties USD 1.35M 2021-12-31 2022 Q1 10-Q 2022-05-20 0001493152-22-014587
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 1.35M 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 142,229 2022-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.16 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.16 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.199 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 420,674 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 66,981 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -485,883 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023742
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 349,938 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1,033 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1,033 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -63,790 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 15,652 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -1.35M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD 48,609 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 205,835 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -29,603 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-03 0001641172-25-002594
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -56,623 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1,594 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap Investments Investments GBP 2.00M 2022-03-31 2022 Q3 10-Q 2022-11-08 0001493152-22-030905
us-gaap Liabilities Liabilities USD 6.06M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 83,201 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap LiabilitiesCurrent Liabilities, Current USD 6.06M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 865,558 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -10,999 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -864,184 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap NotesIssued1 Notes Issued USD 87,409 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap NotesPayable Notes Payable USD 112,752 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040286
us-gaap NotesPayableCurrent Notes Payable, Current USD 42,108 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038323
us-gaap OperatingExpenses Operating Expenses USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 17,459 2024-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap OtherAssets Other Assets USD 1.50M 2025-12-31 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.50M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021919
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -66,981 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 11,553 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 5.36M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap PaymentsToAcquireInterestInSubsidiariesAndAffiliates Payments to Acquire Interest in Subsidiaries and Affiliates GBP 2.00M 2022-03-01 2022-03-31 2022 Q1 10-Q 2022-05-20 0001493152-22-014587
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 10,999 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 67,898 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.68M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 935,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -190,838 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040286
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 8,469 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 10,999 2025-12-31 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 418 2024-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap RelatedPartyCosts Related Party Costs USD 35,668 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 3,318 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-20 0001493152-22-014587
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 69,442 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 79,196 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -12.39M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 98,400 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038323
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 29,847 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.534 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-14 0001493152-26-016559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.657 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.572 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.018 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021919
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.042 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.015 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 100,005 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040286
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 100,005 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.42 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 0.42 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.42 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-15 0001493152-23-005208
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -5.98M 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap StockIssued1 Stock Issued USD 1.50M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 10.00M 2020-10-01 2020-10-05 2022 Q1 10-Q 2022-05-20 0001493152-22-014587
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.58M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 204,879 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 8,469 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001493152-24-010938
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 16.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 16.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-20 0001493152-26-053362

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →